Realtime meta analysis of all significant controlled studies of ivermectin treatment of covid-19.
Search methods, inclusion criteria, all individual study data, and other such information is detailed
here.
As of August 2023:
View attachment 3613426
From the intro to the above
"Ivermectin, better known for antiparasitic activity, is a broad spectrum antiviral with activity against many viruses including H7N7, Dengue, HIV-1, Simian virus 40, Zika, West Nile, Yellow Fever, Japanese encephalitis, Chikungunya, Semliki Forest virus, Human papillomavirus, Epstein-Barr, BK Polyomavirus, and Sindbis virus.
Ivermectin is an inhibitor of importin-α/β-dependent nuclear import of viral proteins, a SARS-CoV-2 3CLpro inhibitor, binds to glycan sites on the SARS-CoV-2 spike protein preventing interaction with blood and epithelial cells and inhibiting hemagglutination, exhibits dose-dependent inhibition of lung injury may inhibit SARS-CoV-2 induced formation of fibrin clots resistant to degradation, may minimize SARS-CoV-2 induced cardiac damage, has immunomodulatory and anti-inflammatory properties, and has an extensive and very positive safety profile...."
Editing Edited to remove the citations for clarity. And because here they linked back to the metastudy rather than to the source that was cited. The citation information is at the metastudy site. Although I am having trouble seeing it on my phone - it shows briefly then autocorrects (or something; I'm not very tech savvy) to another part of the website.